Ainos Inc. acquires 10 patent licenses from TCNT for $5.4M in shares, enhancing AI Nose and point-of-care tech.

Healthcare firm Ainos Inc. obtains exclusive licenses for 10 invention patents and applications from Taiwan Carbon Nano Technology (TCNT), its co-developer, covering US, Germany, China, Japan, and Taiwan. The deal involves $5.4M shares in exchange for the patents, which will boost Ainos' AI Nose and point-of-care testing technologies. The all-stock licensing structure aligns TCNT's interests with Ainos' shareholders, preserving cash for growth.

August 09, 2024
4 Articles